These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 168774)

  • 1. Conjugated estrogens and hypercoagulability.
    von Kaulla E; Droegemueller W; von Kaulla KN
    Am J Obstet Gynecol; 1975 Jul; 122(6):688-92. PubMed ID: 168774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of conjugated estrogens on coagulability in menopausal women.
    Stangel JJ; Innerfield I; Reyniak JV; Stone ML
    Obstet Gynecol; 1977 Mar; 49(3):314-6. PubMed ID: 190571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen-progestin hormonal replacement therapy on blood coagulation and fibrinolysis in postmenopausal women.
    Bonduki CE; Lourenço DM; Motta EL; Soares JM; Haidar MA; Baracat EC
    Clinics (Sao Paulo); 2007 Oct; 62(5):553-60. PubMed ID: 17952314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Natural oestrogens and antithrombin-III levels.
    Greig HB; Notelowitz M
    Lancet; 1975 Feb; 1(7903):412-3. PubMed ID: 46578
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    Jespersen J; Petersen KR; Skouby SO
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):396-403. PubMed ID: 2196812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
    Hedlin AM; Monkhouse FC
    Obstet Gynecol; 1971 Feb; 37(2):225-32. PubMed ID: 5539358
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation and fibrinolysis in estrogen-treated surgically menopausal women.
    Notelovitz M; Kitchens CS; Ware MD
    Obstet Gynecol; 1984 May; 63(5):621-5. PubMed ID: 6326012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of natural oestrogens on coagulation.
    Notelovitz M; Greig HB
    S Afr Med J; 1975 Jan; 49(4):101-5. PubMed ID: 164700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.
    Von Kaulla E; Droegemueller W; Aoki N; Von Kaulla KN
    Am J Obstet Gynecol; 1971 Mar; 109(6):868-73. PubMed ID: 5552623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives, blood clotting and thrombosis.
    Poller L
    Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM
    Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural estrogen and anti-thrombin III activity in postmenopausal women.
    Notelovitz M; Greig HB
    J Reprod Med; 1976 Feb; 16(2):87-90. PubMed ID: 176358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of action of conjugated estrogens as contraceptives. I. Clinical study].
    Fuensalida S; Dabancens A; Guerrero R; Oberti C; Zañartu J; González O
    Rev Chil Obstet Ginecol; 1976; 41(6):333-6. PubMed ID: 208111
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity.
    Howie PW; Mallinson AC; Prentice CR; Horne CH; McNicol GP
    Lancet; 1970 Dec; 2(7687):1329-32. PubMed ID: 4098907
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of oral contraceptives on levels of thyroid hormone, blood coagulation and ceruloplasmin (author's transl)].
    Schenk H; Haralambus I; Leb G; Pickel H; Goebel R
    MMW Munch Med Wochenschr; 1977 Jul; 119(28):941-4. PubMed ID: 70746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and blood coagulation: a critical review.
    Mammen EF
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):781-90. PubMed ID: 7039320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin formation and dissolution in women receiving oral contraceptive drugs.
    Ball AP; McKee PA
    J Lab Clin Med; 1977 Apr; 89(4):751-62. PubMed ID: 845477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium.
    Bremme K; Ostlund E; Almqvist I; Heinonen K; Blombäck M
    Obstet Gynecol; 1992 Jul; 80(1):132-7. PubMed ID: 1534880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.